In this context, it has been demonstrated that autoantibodies against citrullinated proteins are essential in autoimmune-mediated diseases such as rheumatoid arthritis; therefore, using ionomycin as a NET inducer helped us to identify whether PGE2 is able to inhibit the PAD-4 citrullination process. Here, PADI4 is linked to rheumatoid arthritis.